Conceptos Categóricos

Medicina Farmacéutica

  DIURETICS OR ARB ADDED TO CCB IN TREATMENT OF HYPERTENSION
Long-term combination therapy with amlodipine plus amiloride/hydrochlorothiazide or amlodipine plus telmisartan was effective and safe for the high-risk hypertensive patients in China.

Fanghong Lu
Jinan, Cn

  
Especialidades específicas
C.gif Mfa.gif 
Relacionadas
AP.gif  F.gif  Ge.gif  MF.gif  MI.gif  
  SIMULTANEOUS ESTIMATION IN COMBINED DOSAGE FORMS USING UV SPECTROSCOPY
Simultaneous determination of combined pharmaceutical dosage forms, followed by validation, without prior separation, by different simple analytical techniques are reported in this paper. The proposed procedures are rapid, simple, accurate, precise, require no preliminary separation steps, and can be used for routine analysis of drugs in quality control laboratories.

Kareti Srinivasa Rao
Berhampur, In

  
Especialidades específicas
AH.gif Mfa.gif 
Relacionadas
EdM.gif  F.gif  SP.gif  
  INNOVATIVE APPROACHES TO NOVEL SCAFFOLDS AND STRATEGIES FOR INFECTIOUS DISEASES
Our study indicates validity of claims in Ayurved, if medicinal plants selected on basis of its documented use, it leads to more hits which can be scientifically manipulated to find therapies for diseases. In treating infectious diseases, we hope ancient science can contribute to find solutions in developing countries.

Priyanka Jadhav
Gainesville, Us

  
Especialidades específicas
Mfa.gif I.gif 
Relacionadas
F.gif  To.gif  
  INNOVATIVE APPROACHES TO NOVEL SCAFFOLDS AND STRATEGIES FOR INFECTIOUS DISEASES
Our study indicates validity of claims in Ayurved, if medicinal plants selected on basis of its documented use, it leads to more hits which can be scientifically manipulated to find therapies for diseases. In treating infectious diseases, we hope ancient science can contribute to find solutions in developing countries.

Priyanka Jadhav
Gainesville, Us

  
Especialidades específicas
Mfa.gif I.gif 
Relacionadas
F.gif  To.gif  
INTERFERON-BETA TREATMENT AND DISABILITY PROGRESSION IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
We found no strong evidence that interferon-beta treatment was associated with a significant reduction of disability progression in patients with relapsing-remitting multiple sclerosis in an observational study from British Columbia, Canada. Our findings suggest realistic expectations regarding the impact of interferon-beta treatment on multiple sclerosis disability progression in the “real-world” setting.

Afsaneh Shirani
Vancouver, Ca

  
Especialidades específicas
Ne.gif 
Relacionadas
Ep.gif  Fi.gif  Mfa.gif  MI.gif  SP.gif  
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  Avanza 20 páginas
ua71717
-->